Table: q1_q4_2021_prescription_drug_wac_increases , manufacturer_name like U*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id	manufacturer_name	date_reported	ndc_number	drug_product_description	wac_effective_date	wac_increase_amount	wac_after_increase	patent_expiration_date	drug_source_type	unit_sales_volume_in_us	unit_sales_volume_non_public_indicator	cost_increase_factors	cost_increase_factors_non_public_indicator	change_improvement_description	change_improvement_non_public_indicator	acquisition_date	company_acquired_from	acquisition_price	acquisition_price_non_public_indicator	acquisition_price_comment	wac_at_acquisition	wac_year_prior_to_acquisition	year_drug_introduced_to_market	wac_at_intro_to_market	supporting_documents	general_comments
Rx0000090	UCB, Inc	03/31/2021	50474070062	CIMZIA LYOPHOLIZED POWDER FOR INJECTION, 2 X 200 MG VIALS	01/01/2021	185.21	4815.56	02/13/2024	Single Source Drug	1338360000	None	None	1	None	1	None	None	None	None	None	None	None	None	None	None	Consistent with the relevant statutes and regulations, the information provided in this report is limited to that which UCB believes is in the public domain or otherwise publicly available. UCB has not provided a response to the drug acquisition related data fields for this drug product because UCB did not acquire this drug product within the previous five years.
Rx0000090	UCB, Inc	03/31/2021	50474071079	CIMZIA PRE-FILLED SYRINGE KIT, 2 X 200 MG/ML PRE-FILLED SYRINGES	01/01/2021	185.21	4815.56	02/13/2024	Single Source Drug	1338360000	None	None	1	None	1	None	None	None	None	None	None	None	None	None	None	Consistent with the relevant statutes and regulations, the information provided in this report is limited to that which UCB believes is in the public domain or otherwise publicly available. UCB has not provided a response to the drug acquisition related data fields for this drug product because UCB did not acquire this drug product within the previous five years.
Rx0000090	UCB, Inc	03/31/2021	50474071081	CIMZIA PRE-FILLED SYRINGE STARTER KIT, 6 X 200 MG/ML PRE-FILLED SYRINGES	01/01/2021	555.64	14446.68	02/13/2024	Single Source Drug	1338360000	None	None	1	None	1	None	None	None	None	None	None	None	None	None	None	Consistent with the relevant statutes and regulations, the information provided in this report is limited to that which UCB believes is in the public domain or otherwise publicly available. UCB has not provided a response to the drug acquisition related data fields for this drug product because UCB did not acquire this drug product within the previous five years.
Rx0000036	United Therapeutics	12/31/2021	66302020604	Tyvaso (treprostinil) inhalation solution, Tyvaso Institutional Starter Kit (ISK) 1 BOX in 1 KIT > 4 AMPULE in 1 BOX > 2.9 mL in 1 AMPULE	10/01/2021	229.33	4909.49	05/14/2027	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	Price decision was arrived at by taking into account confidential and proprietary information that is not publicly available or within the public domain.
Rx0000036	United Therapeutics	12/31/2021	66302020602	Tyvaso (treprostinil) inhalation solution, Tyvaso Patient Resupply Kit (RSK) 1 BOX in 1 KIT > 28 AMPULE in 1 BOX > 2.9 mL in 1 AMPULE	10/01/2021	887.45	18998.67	05/14/2027	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	Price decision was arrived at by taking into account confidential and proprietary information that is not publicly available or within the public domain.
Rx0000036	United Therapeutics	12/31/2021	66302020601	Tyvaso (treprostinil) inhalation solution, Tyvaso Patient Starter Kit   (PSK) 1 BOX in 1 KIT > 28 AMPULE in 1 BOX > 2.9 mL in 1 AMPULE	10/01/2021	990.00	21194.08	05/14/2027	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	Price decision was arrived at by taking into account confidential and proprietary information that is not publicly available or within the public domain.
Rx0000036	United Therapeutics	12/31/2021	66302020603	Tyvaso (treprostinil) inhalation solution,Tyvaso Supplemental Refill 4 ct 4 AMPULE in 1 BOX > 2.9 mL in 1 AMPULE	10/01/2021	126.78	2714.09	05/14/2027	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	Price decision was arrived at by taking into account confidential and proprietary information that is not publicly available or within the public domain.
Rx0000036	United Therapeutics	03/31/2021	66302001401	Unituxin Dinutuximab; 17.5mg/5mL; Injection/vial; 5mL vial	01/13/2021	1176.20	13056.96	03/01/2027	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	Unit sales data- This information is confidential and proprietary, and not publicly available or within the public domain. Cost increase factors- This information was arrived at by taking into account confidential and proprietary information that is not publicly available or within the public domain. Change/Improvement description- This information was arrived at by taking into account confidential and proprietary information that is not publicly available or within the public domain. Acquisition fields have not been completed because the product was not acquired from another manufacturer within the last 5 years